{"DataElement":{"publicId":"7411374","version":"1","preferredName":"Disease Response Domain Central Nervous System Leukemia Status","preferredDefinition":"An indicator for CNS status.","longName":"RS_RSORRES_CNS","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7411373","version":"1","preferredName":"Disease Response Domain Central Nervous System Disease Response Original Result","preferredDefinition":"A domain for disease response evaluations._The part of the nervous system that consists of the brain, spinal cord, and meninges._The outcome of the disease response assessment as originally received or collected.","longName":"6608777v1.0:7411371v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7411371","version":"1","preferredName":"Central Nervous System Disease Response Original Result","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.:The outcome of the disease response assessment as originally received or collected.","longName":"C12438:C117397","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response Original Result","conceptCode":"C117397","definition":"The outcome of the disease response assessment as originally received or collected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE4A4F44-F9A7-0385-E053-4EBD850A8EF0","latestVersionIndicator":"Yes","beginDate":"2020-09-01","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-01","modifiedBy":"ONEDATA","dateModified":"2020-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE4A4F44-F9B8-0385-E053-4EBD850A8EF0","latestVersionIndicator":"Yes","beginDate":"2020-09-01","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-01","modifiedBy":"SETRAKIN","dateModified":"2020-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3228393","version":"1.1","preferredName":"Central Nervous System Leukemia Status","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges._A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years._A condition or state at a particular time.","longName":"CNS_AT_DX_STATUS","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5D34-5ED8-E040-BB89AD4331BE","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS3","valueDescription":"CNS 3","ValueMeaning":{"publicId":"3228394","version":"1","preferredName":"CNS 3","longName":"3228394v1.00","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are more than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; with or without clinical signs of CNS leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 3","conceptCode":"C116835","definition":"The status of central nervous system leukemia at diagnosis, where there are more than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; with or without clinical signs of CNS leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A16046E6-D7AB-1B8D-E040-BB89AD434ADA","latestVersionIndicator":"Yes","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-20","modifiedBy":"MMADDINENI","dateModified":"2022-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5D3E-5ED8-E040-BB89AD4331BE","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS2","valueDescription":"CNS 2","ValueMeaning":{"publicId":"3228395","version":"1","preferredName":"CNS 2","longName":"3228395v1.00","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; or greater than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is considered negative by Steinherz/Bleyer algorithm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 2","conceptCode":"C116834","definition":"The status of central nervous system leukemia at diagnosis, where there are less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; or greater than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is considered negative by Steinherz/Bleyer algorithm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A16046E6-D7CE-1B8D-E040-BB89AD434ADA","latestVersionIndicator":"Yes","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-20","modifiedBy":"MMADDINENI","dateModified":"2022-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5D48-5ED8-E040-BB89AD4331BE","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS1","valueDescription":"CNS 1","ValueMeaning":{"publicId":"3228396","version":"1","preferredName":"CNS 1","longName":"3228396","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there is an absence of blasts on a cerebral spinal fluid cytospin preparation, regardless of the number of white blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 1","conceptCode":"C116833","definition":"The status of central nervous system leukemia at diagnosis, where there is an absence of blasts on a cerebral spinal fluid cytospin preparation, regardless of the number of white blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A16046E6-D7F1-1B8D-E040-BB89AD434ADA","latestVersionIndicator":"Yes","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5D52-5ED8-E040-BB89AD4331BE","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS 2a","valueDescription":"CNS 2a","ValueMeaning":{"publicId":"4420568","version":"1","preferredName":"CNS 2a","longName":"4420568","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are less than 10 red blood cells and less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 2a","conceptCode":"C116836","definition":"The status of central nervous system leukemia at diagnosis, where there are less than 10 red blood cells and less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5D7B-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5D94-5ED8-E040-BB89AD4331BE","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS 2b","valueDescription":"CNS 2b","ValueMeaning":{"publicId":"4420569","version":"1","preferredName":"CNS 2b","longName":"4420569","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 2b","conceptCode":"C116837","definition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5DA0-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5DB9-5ED8-E040-BB89AD4331BE","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS 2c","valueDescription":"CNS 2c","ValueMeaning":{"publicId":"4420570","version":"1","preferredName":"CNS 2c","longName":"4420570","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and 5 or more white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts and is considered negative by Steinherz/Bleyer algorithm","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 2c","conceptCode":"C116838","definition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and 5 or more white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts and is considered negative by Steinherz/Bleyer algorithm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5DC5-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5DDE-5ED8-E040-BB89AD4331BE","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS 3a","valueDescription":"CNS 3a","ValueMeaning":{"publicId":"4420572","version":"1","preferredName":"CNS 3a","longName":"4420572","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are less than 10 red blood cells and 5 or more white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 3a","conceptCode":"C116840","definition":"The status of central nervous system leukemia at diagnosis, where there are less than 10 red blood cells and 5 or more white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5DEA-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5E03-5ED8-E040-BB89AD4331BE","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS 3b","valueDescription":"CNS 3b","ValueMeaning":{"publicId":"4420573","version":"1","preferredName":"CNS 3b","longName":"4420573","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and 5 or more white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is considered positive by Steinherz/Bleyer algorithm","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 3b","conceptCode":"C116841","definition":"The status of central nervous system leukemia at diagnosis, where there are 10 or more red blood cells and 5 or more white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is considered positive by Steinherz/Bleyer algorithm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5E0F-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5E28-5ED8-E040-BB89AD4331BE","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"CNS 3c","valueDescription":"CNS 3c","ValueMeaning":{"publicId":"4420574","version":"1","preferredName":"CNS 3c","longName":"4420574","preferredDefinition":"The status of central nervous system leukemia at diagnosis, where there are clinical signs of central system leukemia (such as facial nerve palsy, brain/eye involvement, or hypothalamic syndrome).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CNS 3c","conceptCode":"C116843","definition":"The status of central nervous system leukemia at diagnosis, where there are clinical signs of central system leukemia (such as facial nerve palsy, brain/eye involvement, or hypothalamic syndrome).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5E34-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"KUMMEROA","dateModified":"2023-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF82234F-5E4D-5ED8-E040-BB89AD4331BE","beginDate":"2014-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"Not evaluated","valueDescription":"Negation Evaluation","ValueMeaning":{"publicId":"5724610","version":"1","preferredName":"Negation Evaluation","longName":"5724610","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B6C11CE-6798-1EDE-E053-F662850A736C","latestVersionIndicator":"Yes","beginDate":"2017-03-23","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2017-03-23","modifiedBy":"MAESKEB","dateModified":"2020-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BA468D7-E64A-5EC7-E053-F662850AB138","beginDate":"2020-01-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3228392","version":"1","preferredName":"Central Nervous System Leukemia Status","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.:A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:A condition or state at a particular time.","longName":"C12438:C3161:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A16046E6-D77B-1B8D-E040-BB89AD434ADA","latestVersionIndicator":"Yes","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-20","modifiedBy":"ONEDATA","dateModified":"2011-04-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF82234F-5D1E-5ED8-E040-BB89AD4331BE","latestVersionIndicator":"Yes","beginDate":"2011-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-31","modifiedBy":"MAESKEB","dateModified":"2020-01-08","changeDescription":"Versioned to add PVs for COG reuse per request by W.Wong. mc 7/31/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"RS_RSORRES_CNS_DX","type":"COG Form Element","context":"COG"},{"name":"RS_RSORRES_CNSSTATUS","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"What was the CNS status?","type":"Preferred Question Text","description":"What was the CNS status?","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"What is the definitive CNS relapse status?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"What was the CNS status?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"CNS Status:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE46DBA3-FE81-0200-E053-4EBD850AB6F1","latestVersionIndicator":"Yes","beginDate":"2020-09-01","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-01","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 AQT, Alt SN added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"}}